TITLE

Daflon 500 mg in the Treatment of Hemorrhoidal Disease: A Demonstrated Efficacy in Comparison with Placebo

AUTHOR(S)
Godeberge, Phillipe
PUB. DATE
June 1994
SOURCE
Angiology;Jun1994 Supplement, Vol. 45, p574
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Hemorrhoidal disease (HD) is a trophic disorder of the anal canal characterized by recurrent, self-resolving acute episodes. The author reports the results of a double-blind, placebo-controlled trial of the efficacy of Daflon 500 mg in the treatment of acute and chronic symptoms of hemorrhoids. One hundred and twenty outpatients (54 men, 66 women) suffering from an acute episode of HD during the previous two months were included. They received Daflon 500 mg (group D, n = 60) or placebo (group P, n = 60) two tablets daily for two months. The patients were examined at entry (T0) and at two months (T2). At T0, the two groups did not differ in terms of age, sex, weight, height, history of symptoms of HD; 7 patients were excluded from analysis because of treatment failure (group D, n = 2; group P, n = 3), or lost to follow- up (group P, n = 2). In group D, 40% of patients had an attack during the trial with a mean duration of 2.6 days and a mean severity of 1.1 scored on a scale from 1 to 3. These values were significantly different (P < 0.01) from the corresponding values in the P group: 70%, 4.6 days and 1.6 respectively Each symptom and sign was scored on a scale of severity. The overall symptom score, scored from 0 to 15, decreased from 6.6 (group D) and 6.1 (group P) (NS) to 1.1 and 4.0 respectively (P < 0,01) at the end of treatment. The overall sign score, scored from 0 to 9, decreased from 4.9 and 4.5 (NS) to 0.9 and 2.9 (P < 0.01). No significant side effects were noted. This study confirms that Daflon 500 mg is an effective treatment of chronic symptoms as well as of acute symptoms of HD.
ACCESSION #
17933852

 

Related Articles

  • Double-Blind, Placebo-Controlled Evaluation of Clinical Activity and Safety of Daflon 500 mg in the Treatment of Acute Hemorrhoids. Cospite, M. // Angiology;Jun1994 Supplement, Vol. 45, p566 

    One hundred patients with a history of hemorrhoidal disease and suffering from an acute hemorrhoidal attack were randomized into two parallel groups and treated with Daflon 500 mg (D500) or placebo (PL) under double-blind conditions. Daflon 500 mg was administered at the dosage of three tablets...

  • A New Approach to the Treatment of Uncomplicated Cystitis: Results of a Randomized Placebo-Controlled Clinical Trial. Salvatorelli, Nicola; García-Larrosa, alejandro; allegrini, alessandro; Pavone, Daniele // Urologia Internationalis;Oct2016, Vol. 97 Issue 3, p347 

    Objective: To assess the efficacy and safety of a new medical device (MD; a capsule whose main component is a crosslinked protein) in the prevention of uncomplicated cystitis recurrences. Methods: Adult women with acute cystitis symptoms and a ciprofloxacin-susceptible isolate in urine culture...

  • Prediction of Variceal Hemorrhage: A Prospective Study. Snady, Harry; Feinman, Lawrence // American Journal of Gastroenterology;May1988, Vol. 83 Issue 5, p519 

    Prophylactic therapy to prevent the first variceal hemorrhage ceased being recommended for any cirrhotic because risks outweighed benefits. In this study, we identified cirrhotics that have never bled who are most prone to hemorrhage from varices. We developed a numerical grading system which...

  • Stapled Hemorrhoidectomy Stamos, Michael J. // Journal of Gastrointestinal Surgery;May2006, Vol. 10 Issue 5, p627 

    Stapled hemorrhoidectomy or “hemorrhoidopexy” has gained popularity for the treatment of grade 3–4 hemorrhoids, largely due to decreased pain as compared to traditional surgical hemorrhoidectomy. This decreased pain, along with proven short term efficacy, has been supported by...

  • Diagnosis and Current Treatment of Hemorrhoidal Disease. Arullani, Augusto; Cappello, Gianfranco // Angiology;Jun1994 Supplement, Vol. 45, p560 

    Many new surgical and nonsurgical approaches to the treatment of hemorrhoids have been described: sclerotherapy, rubber band ligation, cryosurgery, anal dilatation, infrared photocoagulation, bipolar diathermy, and electrocoagulation. Which one is most effective depends on the size and degree of...

  • Which treatments work best for hemorrhoids? Mounsey, Anne L.; Henry, Susan L. // Journal of Family Practice;Sep2009, Vol. 58 Issue 9, p492 

    The article focuses on the issue on choosing the proper treatment for thrombosed external hemorrhoids. Surgery is the most effective way in treating thrombosed external hemorrhoids, a study had been conducted on 231 patients who have been nonsurgically treated and surgically treated, showed...

  • A Single Intravenous Dose of Ivabradine, a Novel I[sub f] Inhibitor, Lowers Heart Rate but Does Not Depress Left Ventricular Function in Patients with Left Ventricular Dysfunction. Lauck, Gerhard; Reuter, Marcus; Omran, Hegder; Jung, Werner; Manz, Matthias // Cardiology;2003, Vol. 100 Issue 3, p149 

    This randomized, single-blind, placebo-controlled study investigated the effect of ivabradine, a novel heart rate-lowering agent, on echocardiographic indices of left ventricular (LV) systolic function in patients with regional (coronary artery disease) or global (cardiomyopathy) LV dysfunction....

  • Vicriviroc and Peripheral Neuropathy: Results from AIDS Clinical Trials Group 5211. Yeh, Tzu-min; Evans, Scott R.; Gulick, Roy M.; Clifford, David B. // HIV Clinical Trials;Jan/Feb2010, Vol. 11 Issue 1, p51 

    Purpose: To evaluate the effect of vicriviroc (VCV) on peripheral neuropathy (PN), the most prevalent neurological complication of HIV infection in HIV-1-infected treatment- experienced population.Method: A5211 is a randomized placebo- controlled trial evaluating VCV in treatment-experienced HIV...

  • SHORT REPORTS. Akindele, M. Olabode; Odejide, A.O.; Sorensen, E.; Tougaard, I.; Brochner-Mortensen, J.; Wilson, Christine; Eade, O.B.; Elstein, Max; Wright, Ralph; Rundle, J.S.H.; Cameron, S.H.; Ruckley, G.V. // British Medical Journal;7/24/1976, Vol. 2 Issue 6029, p214 

    Presents several reports on the developments of drugs in treating diseases. Effectiveness of amodiaquine hydrochloride; Iatrogenic magnesium intoxication during hydroxycholecalciferol treatment; Management of varicose ulceration.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics